Automated assessment of DNA ploidy, chromatin organization, and stroma fraction to predict prognosis and adjuvant therapy response in patients with stage II colorectal carcinoma.
Year: 2021
Type: article
Study design: Observational Study
Abstract: 43.9%, P=0.015) than those who did not receive adjuvant therapy. In contrast, P, S, N couldn't predict the prognosis of stage I and LMCRC patients. Overall, our data demonstrate that the PSN panel is an accurate prognostic tool that can guide treatment decisions for Chinese stage II CRC patients.
Source: PubMed Central
Authors: Zhixun Zhao, Xiaochen Zhang, Zhongwu Li, Yibo Gao, Xu Guan, Zheng Jiang, Zheng Liu, Ming Yang, Haipeng Chen, Xiaolong Ma, Runkun Yang, Zhao Lu, Hengchang Liu, Lujing Yang, Aiwen Wu, Shuangmei Zou, Xishan Wang
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4206859641
